Clinical Trials Browser

Phase 2 × OTHER × L19-IL2 immunocytokine × Clear all

NCT03705403 2025-01-30

IMMUNOSABR2

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT02735850 2017-05-23

ImmunoSABR

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung